Dogwood Therapeutics GAAP EPS of $1.99 beats by $3.89

Published 2 months ago Positive
Dogwood Therapeutics GAAP EPS of $1.99 beats by $3.89
Auto
* Dogwood Therapeutics press release [https://seekingalpha.com/pr/20199556-dogwood-therapeutics-reports-second-quarter-2025-financial-results] (NASDAQ:DWTX [https://seekingalpha.com/symbol/DWTX]): Q2 GAAP EPS of $1.99 beats by $3.89.
*
Cash on hand of $13.4 million provides operational runway through Q1 2026.

MORE ON DOGWOOD THERAPEUTICS

* Seeking Alpha’s Quant Rating on Virios Therapeutics [https://seekingalpha.com/symbol/DWTX/ratings/quant-ratings]
* Historical earnings data for Virios Therapeutics [https://seekingalpha.com/symbol/DWTX/earnings]
* Financial information for Virios Therapeutics [https://seekingalpha.com/symbol/DWTX/income-statement]